SiSaf Ltd, a UK company developing RNA therapeutics, has named Michael Econs as its clinical advisor to help manage the early clinical development of a therapy for autosomal dominant osteopetrosis Type 2, a rare genetic disease. Dr Econs is professor of medicine and medical and molecular genetics at Indiana University School of Medicine, US. His area of expertise is metabolic bone disease. SiSaf is developing therapeutics for rare genetic skeletal disorders.
SiSaf Ltd announced the appointment on 27 January 2022.
Copyright 2022 Evernow Publishing Ltd